Ustekinumab-aekn Injection, Solution
Product Images NDC 51759-709

Product Visual Gallery

This gallery contains 28 technical images submitted to the FDA as part of the official labeling for Ustekinumab-aekn (NDC 51759-709). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (Avt04 Unbranded 1)

An instructional diagram of a prefilled syringe with labeled parts including plunger head, plunger, needle guard activation clips, needle guard wings, body, viewing window, label, needle, and needle cover. The syringe is intended for drug administration and shows components relevant to handling and safety.*

FDA Label Image

Image (Avt04 Unbranded 10)

An instructional illustration showing a hand holding a syringe angled at 45 degrees, with an arrow indicating the direction of injection into skin or tissue. This figure appears to demonstrate the proper angle for administering the injection.*

FDA Label Image

Image (Avt04 Unbranded 11)

An instructional diagram showing a hand holding a prefilled syringe labeled Ustekinumab-aekn, with the needle about to be inserted into the skin of another person's outstretched hand, demonstrating the injection technique.*

FDA Label Image

Image (Avt04 Unbranded 12)

An instructional black-and-white line drawing showing a hand holding a syringe, with the needle inserted into an injection site on a finger or palm. This illustration likely depicts the administration technique for Ustekinumab-aekn.*

FDA Label Image

Image (Avt04 Unbranded 13)

An instructional illustration showing a hand using a circular adhesive patch, with a finger pressing on the center of the patch. Likely demonstrating application or activation steps for a patch-type medication or device.*

FDA Label Image

Image (Avt04 Unbranded 14)

An instructional illustration labeled 'Figure J' showing a syringe-like device pointing downward toward a container with a straw, indicating proper handling or administration steps for Ustekinumab-aekn.*

FDA Label Image

A (Avt04 Unbranded 15)

Illustration showing components included with Ustekinumab-aekn injection: an adhesive bandage, antiseptic wipes, cotton ball or gauze pads, a vial of Ustekinumab-aekn, a syringe with an attached needle, and an FDA-cleared sharps disposal container.*

FDA Label Image

B (Avt04 Unbranded 16)

An illustration showing recommended injection sites for Ustekinumab-aekn. Highlighted areas in orange include the thigh, upper arm, abdomen, and buttocks.*

FDA Label Image

C (Avt04 Unbranded 17)

An instructional figure labeled 'Figure C' showing a vial with a flip-off cap being removed. The diagram illustrates the action of lifting the cap from the vial.*

FDA Label Image

D (Avt04 Unbranded 18)

Illustration showing hands removing the cap from a small vial, indicated by an arrow pointing upwards, likely demonstrating the first step in preparing a dose of Ustekinumab-aekn injection.*

FDA Label Image

E (Avt04 Unbranded 19)

An instructional illustration labeled Figure E showing two hands assembling a syringe and needle. One hand holds the needle cap, pulling it off from the syringe held by the other hand.*

FDA Label Image

Image (Avt04 Unbranded 2)

An instructional illustration depicting a person holding a syringe at an angle above the skin of an arm, preparing to administer an injection. An arrow indicates the direction and positioning of the syringe relative to the skin.*

FDA Label Image

F (Avt04 Unbranded 20)

An instructional illustration titled 'Figure F' showing a pair of hands drawing liquid from a vial using a syringe, demonstrating a step presumably related to preparation or administration of a medication.*

FDA Label Image

G (Avt04 Unbranded 21)

An instructional illustration showing two hands preparing an injection by drawing liquid from a vial into a syringe. The image depicts the proper technique for withdrawing medication from the vial prior to administration.*

FDA Label Image

H (Avt04 Unbranded 22)

An instructional illustration showing hands preparing an injection by drawing medication from a vial into a syringe. One hand holds the vial and syringe, while the other hand supports the syringe, demonstrating proper technique.*

FDA Label Image

I (Avt04 Unbranded 23)

An instructional illustration showing how to administer an injection using a syringe held at a 45-degree angle, with one hand holding the injection site taut on the skin. Labeled as Figure 1, the image visually guides the proper technique for subcutaneous or intramuscular injection.*

FDA Label Image

J (Avt04 Unbranded 24)

An instructional illustration showing a hand holding a syringe at an angle with an orange arrow pointing to the needle or tip area, likely demonstrating proper injection technique or handling for Ustekinumab-aekn medication.*

FDA Label Image

45 (Avt04 Unbranded 25)

Carton label for Ustekinumab-aekn Injection 45 mg/0.5 mL, a subcutaneous single-dose prefilled syringe. The label prominently displays the product name and strength, with instructions for pharmacist attention and usage. It is labeled for Rx only and manufactured by Teva Pharmaceuticals USA, Inc.*

FDA Label Image

90 (Avt04 Unbranded 26)

Packaging label for Ustekinumab-aekn Injection 90 mg/mL, a single-dose prefilled syringe for subcutaneous use. The label features dosing strength prominently in orange, along with usage instructions and a note for pharmacists about the medication guide. The labeler is Teva Pharmaceuticals USA, Inc.*

FDA Label Image

130 (Avt04 Unbranded 27)

Packaging label for Ustekinumab-aekn Injection 130 mg/26 mL (5 mg/mL) by Teva Pharmaceuticals USA, Inc. The label indicates it is for intravenous infusion only and must be diluted. The package contains one single-dose vial. Storage instructions and manufacturing details are provided, along with a barcode and other regulatory information.*

FDA Label Image

45v (Avt04 Unbranded 28)

Carton packaging label for Ustekinumab-aekn Injection 45 mg/0.5 mL by Teva Pharmaceuticals USA, Inc. The label states it is for subcutaneous use, includes pharmacist attention notes, and indicates the carton contains one single-dose vial. Storage instructions and ingredients are displayed on the back panel along with barcode and manufacturer details.*

FDA Label Image

Image (Avt04 Unbranded 3)

An instructional illustration showing a hand administering a subcutaneous injection with a syringe and needle into the skin of a patient's arm or leg. The image focuses on the injection technique without specific product labeling.*

FDA Label Image

1 (Avt04 Unbranded 4)

A line graph comparing the percentage of patients over 24 weeks among three groups: placebo, Ustekinumab 45 mg, and Ustekinumab 90 mg. The x-axis is marked in weeks, and the y-axis represents patient percentage. The graph shows increased patient percentages in both Ustekinumab groups compared to placebo over time.*

FDA Label Image

Image (Avt04 Unbranded 5)

An instructional illustration of a prefilled syringe of Ustekinumab-aekn showing labeled parts including plunger head, plunger, needle guard activation clips, needle guard wings, body, viewing window, label, needle, and needle cover. This diagram visually identifies components of the injectable device.*

FDA Label Image

B (Avt04 Unbranded 6)

Illustration labeled Figure B showing components for administration of Ustekinumab-aekn, including an adhesive bandage, antiseptic wipes, a cotton ball or gauze pad, a prefilled syringe of Ustekinumab-aekn, and an FDA-cleared sharps disposal container.*

FDA Label Image

Image (Avt04 Unbranded 7)

Injection site diagram for Ustekinumab-aekn showing recommended yellow-shaded areas on the outer thigh, upper arm, abdomen, and buttocks. The illustration highlights appropriate locations for subcutaneous injection on a seated leg, front torso, upper arm, and back buttocks.*

FDA Label Image

Image (Avt04 Unbranded 8)

An instructional illustration showing a hand removing a needle cap from a syringe. The image features an upward orange arrow indicating the removal direction. This is part of a figure related to Ustekinumab-aekn injection preparation.*

FDA Label Image

Image (Avt04 Unbranded 9)

Illustration labeled Figure E showing a hand holding a syringe device with a needle at the bottom, likely demonstrating how to hold or operate the syringe for injection purposes.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.